Seismyc DETECT. DECODE. TRADE. LIVE Pulse
← All stories
Markets 1 sources

Revolution a new overweight at Morgan Stanley on RAS-targeted oncology franchise

Covered by 1 source · 1 article

Covered by
Seekingalpha

All coverage

Seeking Alpha Currents 27m ago

Revolution a new overweight at Morgan Stanley on RAS-targeted oncology franchise

More top stories

11m ago RedHill (RDHL) Acquires Rebyota and Clenpiq Commercialization Rights for $12M Upfront. Can Sales Outpace Royalties? 13m ago Red Robin (RRGB) Completes $89.4M of Refranchising Transactions. Will Debt Relief Offset the Loss of Company-Operated Economics? 14m ago Bank of America flags a $163B risk hanging over stocks 14m ago Transat A.T. Q3 Earnings Call Highlights 15m ago Tsakos Energy Navigation Q2 Earnings Call Highlights 15m ago AI Server Stocks Slide as Two-Day Run Unwinds: Hewlett Packard Enterprise Sinks 4%, Dell Pulls Back, Super Micro Sits Out the Selloff